Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer

BACKGROUND: The aim of this study is to evaluate a new tumour marker, HE4, and to compare it with CA125 in predicting optimal cytoreduction and response to chemotherapy. Thirty patients with advanced epithelial ovarian cancer and multiple sera harvested during neoadjuvant chemotherapy (NAC) were inc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Ovarian Res
Autori principali: Pelissier, Aurélie, Roulot, Aurélie, Guéry, Béatrice, Bonneau, Claire, Bellet, Dominique, Rouzier, Roman
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5039904/
https://ncbi.nlm.nih.gov/pubmed/27677313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0270-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi